212 related articles for article (PubMed ID: 17449903)
1. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Carcinogenesis; 2007 Oct; 28(10):2172-83. PubMed ID: 17449903
[TBL] [Abstract][Full Text] [Related]
2. The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis.
Dunn LL; Sekyere EO; Suryo Rahmanto Y; Richardson DR
Carcinogenesis; 2006 Nov; 27(11):2157-69. PubMed ID: 16704991
[TBL] [Abstract][Full Text] [Related]
3. The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Oncogene; 2007 Sep; 26(42):6113-24. PubMed ID: 17452986
[TBL] [Abstract][Full Text] [Related]
4. Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo.
Bertrand Y; Demeule M; Michaud-Levesque J; Béliveau R
Biochem Biophys Res Commun; 2007 Feb; 353(2):418-23. PubMed ID: 17196552
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
6. Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.
Liu S; Stromberg A; Tai HH; Moscow JA
Mol Cancer Res; 2004 Aug; 2(8):477-87. PubMed ID: 15328374
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
[TBL] [Abstract][Full Text] [Related]
8. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface.
Rolland Y; Demeule M; Fenart L; Béliveau R
Pigment Cell Melanoma Res; 2009 Feb; 22(1):86-98. PubMed ID: 19017294
[TBL] [Abstract][Full Text] [Related]
10. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B
Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139
[TBL] [Abstract][Full Text] [Related]
11. Examination of the distribution of the transferrin homologue, melanotransferrin (tumour antigen p97), in mouse and human.
Sekyere EO; Dunn LL; Richardson DR
Biochim Biophys Acta; 2005 Mar; 1722(2):131-42. PubMed ID: 15716025
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
13. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
[TBL] [Abstract][Full Text] [Related]
14. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
15. Anti-membrane-bound transferrin-like protein antibodies induce cell-shape change and chondrocyte differentiation in the presence or absence of concanavalin A.
Oda R; Suardita K; Fujimoto K; Pan H; Yan W; Shimazu A; Shintani H; Kato Y
J Cell Sci; 2003 May; 116(Pt 10):2029-38. PubMed ID: 12679380
[TBL] [Abstract][Full Text] [Related]
16. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell.
Richardson DR
Eur J Biochem; 2000 Mar; 267(5):1290-8. PubMed ID: 10691965
[TBL] [Abstract][Full Text] [Related]
17. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
18. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29.
Wang Z; Seliger B; Mike N; Momburg F; Knuth A; Ferrone S
Cancer Res; 1998 May; 58(10):2149-57. PubMed ID: 9605759
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion.
Michaud-Levesque J; Demeule M; Béliveau R
Exp Cell Res; 2005 Aug; 308(2):479-90. PubMed ID: 15936756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
